Clostridium difficile infection of the gut.
Dodson
A P
AP
Department of Microbiology, University Hospital, Nottingham. dodson@nottingham.ac.uk
Borriello
S P
SP
D000900:Anti-Bacterial Agents / Q000009:adverse effects; D001426:Bacterial Proteins; D001427:Bacterial Toxins / Q000235:genetics / Q000302:isolation & purification / Q000494:pharmacology; D016360:Clostridioides difficile / Q000235:genetics / Q000472:pathogenicity*; D004198:Disease Susceptibility; D004761:Enterocolitis, Pseudomembranous / Q000150:complications / Q000453:epidemiology / Q000382:microbiology / Q000628:therapy; D004768:Enterotoxins / Q000235:genetics / Q000302:isolation & purification / Q000494:pharmacology; D006801:Humans; D012008:Recurrence
D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D001427:Bacterial Toxins; D004768:Enterotoxins; C041348:tcdA protein, Clostridium difficile; C031815:toxB protein, Clostridium difficile